CCXI

ChemoCentryx News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
ChemoCentryx Inc CCXI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.86 7.45% 12.40 19:59:55
Open Price Low Price High Price Close Price Prev Close
13.06 12.02 13.73 12.18 11.54
more quote information »

Recent News

Date Time Source Heading
6/11/202112:19SEEKChemoCentryx continues winning streak amid looming legal..
6/09/202107:52EDGARSchedule 13g
6/08/202108:30GLOBEChemoCentryx Announces Abstract on Avacopan in..
5/24/202119:55EDGARStatement of Changes in Beneficial Ownership (4)
5/24/202119:40EDGARStatement of Changes in Beneficial Ownership (4)
5/24/202112:54EDGARCurrent Report Filing (8-k)
5/10/202119:49EDGARStatement of Changes in Beneficial Ownership (4)
5/10/202116:31TRMNIs Chemocentryx Stock a Buy Right Now? This Is What You Need..
5/07/202114:57EDGARCurrent Report Filing (8-k)
5/07/202106:45SEEKChemoCentryx reports outcome of FDA’s expert panel meeting..
5/06/202123:37GLOBEChemoCentryx Announces Results of FDA Advisory Committee..
5/06/202117:15SEEKFDA panel split 9-9 on efficacy for Chemocentryx's..
5/04/202112:20SEEKChemocentryx shares plunge 47% as FDA report identifies..
5/03/202106:05EDGARQuarterly Report (10-q)
4/29/202116:26SEEKChemoCentryx EPS misses by $0.03, beats on revenue
4/29/202116:20EDGARCurrent Report Filing (8-k)
4/29/202116:05GLOBEChemoCentryx Reports First Quarter 2021 Financial Results..
4/22/202108:30GLOBEChemoCentryx to Hold First Quarter 2021 Financial Results..
4/09/202108:30GLOBEChemoCentryx’s Oral PD-L1 inhibitor, CCX559, Featured in..
4/07/202116:10EDGARProxy Statement (definitive) (def 14a)
4/07/202108:30GLOBEChemoCentryx to Host Virtual R&D Day on April 14, 2021
3/08/202108:30GLOBEChemoCentryx Announces Appointment of Susan M. Kanaya to..
3/03/202116:17EDGARCurrent Report Filing (8-k)
3/01/202116:52EDGARCurrent Report Filing (8-k)
3/01/202116:38EDGARAnnual Report (10-k)
3/01/202116:20EDGARCurrent Report Filing (8-k)
3/01/202116:16SEEKChemoCentryx EPS misses by $0.10, misses on revenue
3/01/202116:05GLOBEChemoCentryx Reports Fourth Quarter and Full Year 2020..
2/25/202108:30GLOBEChemoCentryx to Present at Two Upcoming Investor Conferences
2/24/202112:13EDGARInitial Statement of Beneficial Ownership (3)
2/24/202109:11SEEKChemoCentryx names new EVP & COO
2/24/202108:30GLOBEChemoCentryx Appoints Tausif (‘Tosh’) Butt as Executive Vice..
2/23/202108:30GLOBEChemoCentryx to Hold Fourth Quarter and Full Year 2020..
2/18/202109:15SEEKChemoCentryx announces peer reviewed publication of Phase 3..
2/17/202117:00GLOBEChemoCentryx Announces Publication in The New England..
2/16/202116:52EDGARAmended Statement of Ownership (sc 13g/a)
2/16/202115:02EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202110:49EDGARStatement of Ownership (sc 13g)
2/03/202114:15EDGARSchedule 13g
1/06/202108:30GLOBEChemoCentryx to Participate in Two Upcoming Investor..
12/22/202004:09TRMNChemoCentryx’s Releases Avacopan Trial Results For Rare..
12/21/202016:16EDGARCurrent Report Filing (8-k)
12/21/202016:05GLOBEChemoCentryx and VFMCRP Provide Topline Results from..
11/19/202008:30GLOBEChemoCentryx to Present at Two Upcoming Investor Conferences
11/10/202009:03EDGARSchedule 13g
11/09/202016:21EDGARQuarterly Report (10-q)
11/09/202016:17EDGARCurrent Report Filing (8-k)
11/09/202016:05GLOBEChemoCentryx Reports Third Quarter 2020 Financial Results..
11/06/202008:30GLOBEChemoCentryx Announces Plenary Session at ACR Convergence..
11/04/202016:16EDGARCurrent Report Filing (8-k)
See more news about this stock »


Your Recent History
NASDAQ
CCXI
ChemoCentr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.